首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >A fast affinity extraction methodology for rapid screening of bioactive compounds specifically binding to beta2-adrenergic receptor from Xie-Bai-San
【24h】

A fast affinity extraction methodology for rapid screening of bioactive compounds specifically binding to beta2-adrenergic receptor from Xie-Bai-San

机译:一种快速亲和力提取方法,用于快速筛选来自谢百圣的β2-肾上腺素能受体特异性结合的生物活性化合物

获取原文
获取原文并翻译 | 示例
       

摘要

Despite promising progress in series of techniques for drug discovery, the number of approved drugs has decreased in recent decades due to the lack of high efficient methods for candidate screening. In this work, immobilized beta2-adrenergic receptor was utilized to develop a new method for screening bioactive compounds from complex prescription, involving oriented immobilization of beta2-adrenergic receptor through diazonium reaction, the fast affinity extraction of bioactive compounds from Xie-Bai-San and the identification of these compounds by time of flight mass spectrometry. Valine, 4-hydroxyl resveratrol and kukoamine B were identified as the bioactive compounds specifically binding to beta2-adrenergic receptor in Xie-Bai-San. The binding of these compounds to the receptor occurred on four amino acid residues, viz., Asp 113, Ser 204, Ser 207, and Phe 290 in the crystal structure of beta2-adrenergic receptor. Hydrogen bond and hydrophobic force were believed to drive the binding of the compounds to beta2-adrenergic receptor on these residues. The results indicated that the proposed methodology has advantages on rapid, high throughput, and specific analysis, meanwhile, it has the capacity to probe the binding sites of the screened bioactive compounds. Fast affinity extraction methodology is expected to become a powerful alternative, which is superior in rapid screening of bioactive compounds from complex matrices such as traditional Chinese medicine.
机译:尽管有希望的药物发现技术进展,但由于候选筛查缺乏高效的方法,近几十年来批准的药物数量减少。在这项工作中,利用固定化的β2-肾上腺素能受体来开发一种从复杂的处方中筛选生物活性化合物的新方法,涉及通过重氮反应的β2-肾上腺素能受体的定向固定,来自Xie-bai-san的生物活性化合物的快速亲和力提取通过飞行时间质谱法鉴定这些化合物。将缬氨酸,4-羟基白藜芦醇和Kukoamine B鉴定为具有Xie-Bai-San的β2-肾上腺素能受体的生物活性化合物。这些化合物在β-肾上腺素能受体的晶体结构中的四个氨基酸残基,Viz,asp13,ser 204,ser 207和pHE 290中发生了这些化合物对受体的结合。据信氢键和疏水力驱动化合物对这些残留物的β2-肾上腺素能受体的结合。结果表明,该方法具有快速,高通量和特异性分析的优点,同时,它具有探测筛选的生物活性化合物的结合位点的能力。快速亲和提取方法预计将成为一种强大的替代方案,其在复杂基质如中医中的复杂基质的快速筛选中优异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号